Chrysoula Vlassi

1.2k total citations
19 papers, 889 citations indexed

About

Chrysoula Vlassi is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Chrysoula Vlassi has authored 19 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 9 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Chrysoula Vlassi's work include HIV Research and Treatment (14 papers), HIV/AIDS Research and Interventions (7 papers) and Hepatitis C virus research (5 papers). Chrysoula Vlassi is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS Research and Interventions (7 papers) and Hepatitis C virus research (5 papers). Chrysoula Vlassi collaborates with scholars based in Italy, United States and France. Chrysoula Vlassi's co-authors include Marinella Giulianelli, Andrea Antinori, Valerio Tozzi, Pietro Balestra, Pasquale Narciso, Angela Corpolongo, Ubaldo Visco‐Comandini, Rita Bellagamba, Simonetta Galgani and Maria Flora Salvatori and has published in prestigious journals such as PLoS ONE, Gut and AIDS.

In The Last Decade

Chrysoula Vlassi

19 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chrysoula Vlassi Italy 13 648 396 297 198 133 19 889
Angela Corpolongo Italy 17 578 0.9× 546 1.4× 269 0.9× 251 1.3× 85 0.6× 56 1.1k
Lucy Garvey United Kingdom 17 506 0.8× 421 1.1× 276 0.9× 204 1.0× 39 0.3× 38 826
Tauheed Zaman United States 9 483 0.7× 227 0.6× 173 0.6× 188 0.9× 304 2.3× 14 777
Anupa Kamat United States 11 917 1.4× 483 1.2× 475 1.6× 218 1.1× 215 1.6× 14 1.2k
Jerome H. Kim United States 12 698 1.1× 495 1.3× 220 0.7× 211 1.1× 98 0.7× 24 852
Michael Roche Australia 23 1.0k 1.6× 560 1.4× 131 0.4× 196 1.0× 407 3.1× 52 1.3k
Scott Letendre United States 9 843 1.3× 587 1.5× 443 1.5× 163 0.8× 41 0.3× 14 1.0k
Amy Krambrink United States 10 547 0.8× 477 1.2× 162 0.5× 118 0.6× 102 0.8× 15 655
Erin N. Shirk United States 16 690 1.1× 363 0.9× 206 0.7× 173 0.9× 285 2.1× 26 947
Josué Pérez‐Santiago United States 19 453 0.7× 382 1.0× 167 0.6× 182 0.9× 73 0.5× 47 932

Countries citing papers authored by Chrysoula Vlassi

Since Specialization
Citations

This map shows the geographic impact of Chrysoula Vlassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chrysoula Vlassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chrysoula Vlassi more than expected).

Fields of papers citing papers by Chrysoula Vlassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chrysoula Vlassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chrysoula Vlassi. The network helps show where Chrysoula Vlassi may publish in the future.

Co-authorship network of co-authors of Chrysoula Vlassi

This figure shows the co-authorship network connecting the top 25 collaborators of Chrysoula Vlassi. A scholar is included among the top collaborators of Chrysoula Vlassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chrysoula Vlassi. Chrysoula Vlassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cimini, Eleonora, Chiara Agrati, Gianpiero D’Offizi, et al.. (2015). Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS ONE. 10(6). e0129771–e0129771. 19 indexed citations
2.
Nardacci, Roberta, Alessandra Amendola, Fabiola Ciccosanti, et al.. (2014). Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients. Autophagy. 10(7). 1167–1178. 67 indexed citations
3.
Cimini, Eleonora, Cécile Bonnafous, Hélène Sicard, et al.. (2013). In Vivo Interferon-Alpha/Ribavirin Treatment Modulates Vγ9Vδ2 T-Cell Function During Chronic HCV Infection. Journal of Interferon & Cytokine Research. 33(3). 136–141. 5 indexed citations
4.
Rozera, Gabriella, Isabella Abbate, Chrysoula Vlassi, et al.. (2013). Quasispecies tropism and compartmentalization in gut and peripheral blood during early and chronic phases of HIV-1 infection: possible correlation with immune activation markers. Clinical Microbiology and Infection. 20(3). O157–O166. 17 indexed citations
5.
Rozera, Gabriella, Isabella Abbate, Massimo Ciccozzi, et al.. (2012). Ultra‐deep sequencing reveals hidden HIV‐1 minority lineages and shifts of viral population between the main cellular reservoirs of the infection after therapy interruption. Journal of Medical Virology. 84(6). 839–844. 11 indexed citations
6.
Cimini, Eleonora, Cécile Bonnafous, Veronica Bordoni, et al.. (2012). Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection. PLoS ONE. 7(5). e37014–e37014. 17 indexed citations
7.
Mancone, Carmine, Corinna Steindler, Laura Santangelo, et al.. (2010). Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut. 60(3). 378–386. 67 indexed citations
8.
Sacchi, Alessandra, Chiara Agrati, Gianpiero D’Offizi, et al.. (2010). The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients. Clinical Immunology. 138(2). 178–186. 2 indexed citations
9.
Abbate, Isabella, Chrysoula Vlassi, Gabriella Rozera, et al.. (2010). Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection. AIDS. 25(5). 611–617. 36 indexed citations
10.
Tozzi, Valerio, Pietro Balestra, Maria Flora Salvatori, et al.. (2009). Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(1). 56–63. 109 indexed citations
11.
Poccia, Fabrizio, Cristiana Gioia, Federico Martini, et al.. (2009). Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells. AIDS. 23(5). 555–565. 50 indexed citations
12.
Lalle, Eleonora, Douglas Horejsh, Isabella Abbate, et al.. (2009). Ability of peripheral blood mononuclear cells to activate interferon response in vitro is predictive of virological response in HCV patients.. PubMed. 22(3). 153–60. 9 indexed citations
13.
Dianzani, F., Gabriella Rozera, Isabella Abbate, et al.. (2008). Interferon May Prevent HIV Viral Rebound After HAART Interruption in HIV Patients. Journal of Interferon & Cytokine Research. 28(1). 1–3. 19 indexed citations
14.
Nicastri, Emanuele, Chrysoula Vlassi, Silvia Pittalis, et al.. (2007). Imported malaria at Italy’s National Institute for Infectious Diseases Lazzaro Spallanzani, 1984–2003. European Journal of Clinical Microbiology & Infectious Diseases. 26(3). 175–179. 16 indexed citations
15.
Tozzi, Valerio, Pietro Balestra, Rita Bellagamba, et al.. (2007). Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 174–182. 242 indexed citations
16.
Rozera, Gabriella, Isabella Abbate, Gianpiero D’Offizi, et al.. (2007). Virological characterization of patients treated early is able to control HIV‐1 replication after multiple cycles of structured therapy interruption. Journal of Medical Virology. 79(8). 1047–1054. 3 indexed citations
17.
Tozzi, Valerio, Pietro Balestra, Chrysoula Vlassi, & Maria Flora Salvatori. (2007). Author's Response to “Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment”. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(5). 657–658. 2 indexed citations
18.
Tozzi, Valerio, Pietro Balestra, Diego Serraino, et al.. (2005). Neurocognitive Impairment and Survival in a Cohort of HIV-Infected Patients Treated with HAART. AIDS Research and Human Retroviruses. 21(8). 706–713. 94 indexed citations
19.
Tozzi, Valerio, Pietro Balestra, Patrizia Lorenzini, et al.. (2005). Prevalence and risk factors for human immunodeficiency virus–associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of NeuroVirology. 11(3). 265–273. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026